Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.

Pereira, Valéria Rêgo Alves; Lorena, Virginia Maria Barros de; Nakazawa, Mineo; Luna, Carlos Feitosa; Silva, Edimilson Domingos da; Ferreira, Antonio Gomes Pinto; Krieger, Marco Aurélio; Goldenberg, Samuel; Soares, Milena Botelho Pereira; Coutinho, Eridan de Medeiros; Oliveira, Rodrigo Corrêa; Gomes, Yara de Miranda.
Artículo en Inglés | ARCA | ID: arc-9993

Documentos relacionados

  1. Co-administration of chitin micro-particle and Leishmania antigen proposed a new immune adjuvant against experimental leishmaniasis.
  2. Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens.
  3. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas' disease.
  4. Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting.
  5. Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites.
  6. Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.
  7. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
  8. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.
  9. The use of peptides for immunodiagnosis of human Chagas disease.
  10. Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic.